Literature DB >> 3426393

Transsexuals who have not undergone surgery: a follow-up study.

G Kockott1, E M Fahrner.   

Abstract

Transsexuals who had not undergone surgery, although it had been offered to them providing they fulfilled the usual requirements, were classified into various subgroups, measured according to their attitude towards sex reassignment surgery: they were transsexuals with an unaltered wish for surgery, transsexuals who were ambivalent towards surgery (hesitating patients), and transsexuals who had relinquished their wish for surgery and lived in the initial gender role. Whereas transsexuals with an unaltered wish for surgery did not differ substantially from transsexuals who had had surgery, the hesitating patients were noticeably older, more often married, more often had children of their own, their partnerships were of long duration, and exclusively with partners of the opposite biological sex. These characteristics were seen when the diagnosis was first made. They can therefore be considered prognostic criteria for this subgroup. Transsexuals who relinquished their wish for surgery did not differ substantially from transsexuals with an unaltered wish for surgery. The reasons for relinquishing the wish for surgery were individual or could not be clearly established. At the time of follow-up, all transsexuals who had not undergone surgery indicated that they were experiencing the same degree of difficulty with respect to social adjustment as at the time of diagnosis. Slight improvements were seen in patients with an unaltered wish for surgery. Significant changes were seen only in transsexuals who had surgery. Transsexuals who have not had surgery and have no present wish for it are in the minority. Hesitating patients have a particular need for psychotherapy.

Entities:  

Mesh:

Year:  1987        PMID: 3426393     DOI: 10.1007/BF01541715

Source DB:  PubMed          Journal:  Arch Sex Behav        ISSN: 0004-0002


  7 in total

1.  [Psychosocial integration of operated transsexual patients].

Authors:  E M Fahrner; G Kockott; G Duran
Journal:  Nervenarzt       Date:  1987-06       Impact factor: 1.214

2.  Sex reassignment. Follow-up.

Authors:  J K Meyer; D J Reter
Journal:  Arch Gen Psychiatry       Date:  1979-08

Review 3.  Outcome of sex reassignment surgery.

Authors:  B Lundström; I Pauly; J Wålinder
Journal:  Acta Psychiatr Scand       Date:  1984-10       Impact factor: 6.392

4.  Gender dysphoria, gender reorientation, and the clinical management of transsexualism.

Authors:  R Blanchard; B W Steiner; L H Clemmensen
Journal:  J Consult Clin Psychol       Date:  1985-06

5.  Follow-up of 17 biologic male transsexuals after sex-reassignment surgery.

Authors:  D D Hunt; J L Hampson
Journal:  Am J Psychiatry       Date:  1980-04       Impact factor: 18.112

6.  Methodological problems in assessing sex-reassignment surgery: a reply to Meyer and Reter.

Authors:  M Fleming; C Steinman; G Bocknek
Journal:  Arch Sex Behav       Date:  1980-10

7.  Follow-up of females with gender identity disorders.

Authors:  E McCauley; A A Ehrhardt
Journal:  J Nerv Ment Dis       Date:  1984-06       Impact factor: 2.254

  7 in total
  5 in total

Review 1.  Transsexual healing: medicaid funding of sex reassignment surgery.

Authors:  E B Gordon
Journal:  Arch Sex Behav       Date:  1991-02

2.  Surgical sex reassignment: a comparative survey of international centers.

Authors:  M E Petersen; R Dickey
Journal:  Arch Sex Behav       Date:  1995-04

3.  Varieties of autogynephilia and their relationship to gender dysphoria.

Authors:  R Blanchard
Journal:  Arch Sex Behav       Date:  1993-06

4.  Androgen receptor repeat length polymorphism associated with male-to-female transsexualism.

Authors:  Lauren Hare; Pascal Bernard; Francisco J Sánchez; Paul N Baird; Eric Vilain; Trudy Kennedy; Vincent R Harley
Journal:  Biol Psychiatry       Date:  2008-10-28       Impact factor: 13.382

5.  The Use of Whole Exome Sequencing in a Cohort of Transgender Individuals to Identify Rare Genetic Variants.

Authors:  J Graham Theisen; Viji Sundaram; Mary S Filchak; Lynn P Chorich; Megan E Sullivan; James Knight; Hyung-Goo Kim; Lawrence C Layman
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.